Molecular and functional analysis of Shiga toxin-induced response patterns in human vascular endothelial cells.

Enterohemorrhagic Escherichia coli (EHEC) is the major cause of hemolyticuremic syndrome (HUS) characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure. EHEC produces one or more Shiga toxins (Stx1 and Stx2), and it was assumed that Stx's only relevant biologic activity was cell destruction through inhibition of protein synthesis. However, recent data indicate that in vivo the cytokine milieu may determine whether endothelial cells survive or undergo apoptosis/necrosis when exposed to Stxs. In this study, we analyzed the genome-wide expression patterns of human endothelial cells stimulated with subinhibitory concentrations of Stxs in order to characterize the genomic expression program involved in the vascular pathology of HUS. We found that Stxs elicited few, but reproducible, changes in gene expression. The majority of genes reported in this study encodes for chemokines and cytokines, which might contribute to the multifaceted inflammatory response of host endothelial cells observed in patients suffering from EHEC disease. In addition, our data provide for the first time molecular insights into the epidemiologically well-established higher pathogenicity of Stx2 over Stx1.

[1]  G. Remuzzi,et al.  Shiga toxin-2 triggers endothelial leukocyte adhesion and transmigration via NF-kappaB dependent up-regulation of IL-8 and MCP-1. , 2002, Kidney international.

[2]  H. Karch,et al.  Shiga Toxin-Producing Escherichia coli Infection and Antibodies against Stx2 and Stx1 in Household Contacts of Children with Enteropathic Hemolytic-Uremic Syndrome , 2002, Journal of Clinical Microbiology.

[3]  M. Probst-Kepper,et al.  CXCR4/CXCL12 expression and signalling in kidney cancer , 2002, British Journal of Cancer.

[4]  Michael Karin,et al.  NF-κB at the crossroads of life and death , 2002, Nature Immunology.

[5]  D. Acheson,et al.  Shiga Toxins Induce, Superinduce, and Stabilize a Variety of C-X-C Chemokine mRNAs in Intestinal Epithelial Cells, Resulting in Increased Chemokine Expression , 2001, Infection and Immunity.

[6]  G. Remuzzi,et al.  Verotoxin-1-induced up-regulation of adhesive molecules renders microvascular endothelial cells thrombogenic at high shear stress. , 2001, Blood.

[7]  E. Seidman,et al.  Pathogenesis of Shiga Toxin-Associated Hemolytic Uremic Syndrome , 2001, Pediatric Research.

[8]  H. Karch,et al.  Antibody Response to Shiga Toxins Stx2 and Stx1 in Children with Enteropathic Hemolytic-Uremic Syndrome , 2001, Journal of Clinical Microbiology.

[9]  B. Aggarwal,et al.  Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-κB , 2000, Annals of the rheumatic diseases.

[10]  S. Tzipori,et al.  Escherichia coli 0157:H7 Strains That Express Shiga Toxin (Stx) 2 Alone Are More Neurotropic for Gnotobiotic Piglets Than Are Isotypes Producing Only Stx1 or Both Stx1 and Stx2 , 2000 .

[11]  D. Acheson,et al.  Shiga Toxins Stimulate Secretion of Interleukin-8 from Intestinal Epithelial Cells , 1999, Infection and Immunity.

[12]  Chen,et al.  Simultaneous Quantification of Six Human Cytokines in a Single Sample Using Microparticle-based Flow Cytometric Technology. , 1999, Clinical chemistry.

[13]  L. Khachigian,et al.  Vascular smooth muscle cell proliferation and regrowth after mechanical injury in vitro are Egr-1/NGFI-A-dependent. , 1999, The American journal of pathology.

[14]  D. Vestweber,et al.  Molecular mechanisms that control leukocyte extravasation: the selectins and the chemokines. , 1999, Histochemistry and cell biology.

[15]  S. McEwen,et al.  Associations between Virulence Factors of Shiga Toxin-ProducingEscherichia coli and Disease in Humans , 1999, Journal of Clinical Microbiology.

[16]  M. Gunn,et al.  A high endothelial cell-derived chemokine induces rapid, efficient, and subset-selective arrest of rolling T lymphocytes on a reconstituted endothelial substrate. , 1998, Journal of immunology.

[17]  V. L. Tesh,et al.  Shiga Toxin Type 1 Activates Tumor Necrosis Factor-α Gene Transcription and Nuclear Translocation of the Transcriptional Activators Nuclear Factor-κB and Activator Protein-1 , 1998 .

[18]  James C. Paton,et al.  Pathogenesis and Diagnosis of Shiga Toxin-Producing Escherichia coli Infections , 1998, Clinical Microbiology Reviews.

[19]  F. Gunzer,et al.  Construction and characterization of an isogenic slt-ii deletion mutant of enterohemorrhagic Escherichia coli. , 1998, Infection and immunity.

[20]  M J May,et al.  NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. , 1998, Annual review of immunology.

[21]  Yang Wang,et al.  Verotoxin and ricin have novel effects on preproendothelin-1 expression but fail to modify nitric oxide synthase (ecNOS) expression and NO production in vascular endothelium. , 1998, The Journal of clinical investigation.

[22]  T. Collins,et al.  Inducible expression of Egr-1-dependent genes. A paradigm of transcriptional activation in vascular endothelium. , 1997, Circulation research.

[23]  K. Ebnet,et al.  Borrelia burgdorferi activates nuclear factor-kappa B and is a potent inducer of chemokine and adhesion molecule gene expression in endothelial cells and fibroblasts. , 1997, Journal of immunology.

[24]  K. Liddell.  Escherichia coli 0157: outbreak in central Scotland , 1997, The Lancet.

[25]  D. Acheson,et al.  Translocation of Shiga toxin across polarized intestinal cells in tissue culture , 1996, Infection and immunity.

[26]  J. Lanser,et al.  Molecular microbiological investigation of an outbreak of hemolytic-uremic syndrome caused by dry fermented sausage contaminated with Shiga-like toxin-producing Escherichia coli , 1996, Journal of clinical microbiology.

[27]  Q. Hamid,et al.  Histamine induces interleukin-8 secretion by endothelial cells. , 1994, Blood.

[28]  D. Acheson,et al.  Patients with haemolytic uraemic syndrome caused by Escherichia coli 0157: Absence of antibodies to Vero cytotoxin 1 (VT1) or VT2 , 2022 .

[29]  T. Cheasty,et al.  Vero cytotoxin-producing Escherichia coli, particularly serogroup O 157, associated with human infections in the United Kingdom: 1989–91 , 1993, Epidemiology and Infection.

[30]  S. O’Brien,et al.  Linkage mapping of the human CSF2 and IL3 genes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[31]  D. Acheson,et al.  Purification of Shiga toxin and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized P1 glycoprotein and production of cross-reactive monoclonal antibodies , 1989, Infection and immunity.

[32]  J. Wells,et al.  Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum. , 1988, Annals of internal medicine.

[33]  T. Yutsudo,et al.  Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. , 1988, European journal of biochemistry.

[34]  B. Rowe,et al.  Properties of strains of Escherichia coli belonging to serogroup O 157 with special reference to production of Vero cytotoxins VTl and VT2 , 1987, Epidemiology and Infection.

[35]  C. Merril,et al.  A highly sensitive silver stain for detecting proteins and peptides in polyacrylamide gels. , 1979, Analytical biochemistry.

[36]  C R Merril,et al.  Trace polypeptides in cellular extracts and human body fluids detected by two-dimensional electrophoresis and a highly sensitive silver stain. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[37]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[38]  A. Spurr.  A low-viscosity epoxy resin embedding medium for electron microscopy. , 1969, Journal of ultrastructure research.